Blepha EyeBag® | Warming Eye Mask | Relief of Dry, Tired and Sore Eyes | Microwaveable | Previously the MGDRx® EyeBag

Product Information

Ngo W, Srinivasan S, Jones L. An eyelid warming device for the management of meibomian gland dysfunction. J Optom. 2019;12(2):120–30. Greiner JV. A single LipiFlow ® thermal pulsation system treatment improves meibomian gland function and reduces dry eye symptoms for 9 months. Curr Eye Res. 2012;37(4):272–8. The EyeBag is a silk and cotton device that can be re-heated up to 200 times in a microwave. Simply heat for 30 or 40 seconds on full power and the EyeBag will stay warm for up to 10 minutes. For the treatment of Meibomian Gland Dysfunction and relief of the following: Jester J.V., Nicolaides N., Kiss-Palvolgyi I., Smith R.E. Meibomian gland dysfunction. II. The role of keratinization in a rabbit model of MGD. Investigative Ophthalmology & Visual Science. 1989;30:936–945. Albietz JM, Schmid KL. Intense pulsed light treatment and meibomian gland expression for moderate to advanced meibomian gland dysfunction. Clin Exp Optom. 2018;101(1):23–33.

IPL improved ocular symptoms, TBUT, TMH, corneal staining, lid margin abnormalities, and meibum secretion Once the EyeBag is comfortably warm to the touch it can be used as described in the instruction booklet. The EyeBag® can be used as a treatment for sore gritty eyes, dry eye syndrome, Meibomian Gland Dysfunction, Chalazion treatment, Stye treatment and Blepharitis treatment. Satjawatcharaphong P, Ge S, Lin MC. Clinical outcomes associated with thermal pulsation system treatment. Optom Vis Sci. 2015;92(9):334–41.TheBlepha EyeBag (Formally MDG Rx Eyebag ®)is a patented, CE marked Class 1 medical device registered with the Medicines and Healthcare products Regulatory Agency (MHRA). Yin Y, Liu N, Gong L, Song N. Changes in the meibomian gland after exposure to intense pulsed light in meibomian gland dysfunction (MGD) patients. Curr Eye Res. 2018;43(3):308–13. Twenty-five participants completed the study (mean age 38±15 years, 7 male). There was a significant change in OSDI over time for the EyeBag group (mean[lower 95% CI, upper 95% CI], baseline: 39.1[31.1,47.0], 2wk: 26.8[19.7,33.9], 4wk: 26.6[16.5,36.7], 8wk: 27.7[18.4,37.0]; p=0.01), but not in the control group (p=0.22), but no significant difference between groups at all time points (all p>0.27). Symptoms immediately improved after conducting the EyeBag based on at-home CSQ scores (Δ=-5.0 points, p<0.01), but not in the control group. For both groups, there was no significant change (p-value EyeBag,p-value control) in MG score (0.21,0.17) and NIBUT (0.49,0.06) over time. Delays also often occur at Easter because the depots are shut on Easter Monday & Good Friday and hence post builds up. Dr. Krawitz has served in academia as an Assistant Clinical Professor of Ophthalmology in Manhattan. He has also frequently lectured at professional ophthalmic meetings regarding his highly successful surgical techniques for cataracts, glaucoma and specialty intraocular lenses.

Probing improved ocular symptoms (OSDI) and TBUT for up to 3months as well as reduced hyperaemia and lid margin vascularity Square G. Scottish Intercollegiate Guidelines Network SIGN 50. A guideline developer's handbook. SIGN, Edinburgh;2008. IPL plus MGX improved ocular symptoms (SPEED score) and TBUT as well as reduced the levels of inflammatory markers in tear fluid Randomised masked clinical trial of the MGDRx EyeBag® for the treatment of meibomian gland dysfunction-related evaporative dry eye. Bilkhu PS, Naroo SA, Wolffsohn JS. Br J Ophthalmol 2014;98:1707-171

Doan S, Chiambaretta F, Baudouin C. Evaluation of an eyelid warming device (Blephasteam ®) for the management of ocular surface diseases in France: the ESPOIR study. J Fr Ophtalmol. 2014;37(10):763–72. Wang MTM, Jaitley Z, Lord SM, Craig JP. Comparison of self-applied heat therapy for meibomian gland dysfunction. Optom Vis Sci. 2015;92(9):321–6.